Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 30  Show
  1. 1
    "Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas."
    Jonkers J., Korswagen H.C., Acton D., Breuer M., Berns A.
    EMBO J. 16:441-450(1997) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 and mapped to 5 other entries.

  2. 2
    Jonkers J., Korswagen H.C., Acton D., Breuer M., Berns A.
    Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases
    Cited for: SEQUENCE REVISION TO 170.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  3. 3
    "Molecular cloning and expression of proto-oncogene FRAT1 in human cancer."
    Saitoh T., Mine T., Katoh M.
    Int. J. Oncol. 20:785-789(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
    Category: Sequences.
    Tissue: Lung.
    Source: UniProtKB/Swiss-Prot (reviewed).
  4. 4
    "The DNA sequence and comparative analysis of human chromosome 10."
    Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., Taylor A., Battles J.
    , Bird C.P., Ainscough R., Almeida J.P., Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.
    Nature 429:375-381(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
    Category: Sequences.
    Tissue: Testis.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2061 other entries.

  5. 5
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Tissue: Testis.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50481 other entries.

  6. 6
    "Casein kinase I epsilon enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced accumulation of beta-catenin."
    Hino S., Michiue T., Asashima M., Kikuchi A.
    J. Biol. Chem. 278:14066-14073(2003) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH DVL1, ROLE IN WNT SIGNALING.
    Category: Function, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 and mapped to 14 other entries.

  7. 7
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-88, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: PTM / Processing, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1396 other entries.

  8. 8
    "The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation."
    Bax B., Carter P.S., Lewis C., Guy A.R., Bridges A., Tanner R., Pettman G., Mannix C., Culbert A.A., Brown M.J.B., Smith D.G., Reith A.D.
    Structure 9:1143-1152(2001) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 198-223 IN COMPLEX WITH GSK-3.
    Category: Interaction, Structure.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  9. 9
    "Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1."
    Li L., Yuan H., Weaver C.D., Mao J., Farr G.H., Sussman D.J., Jonkers J., Kimelman D., Wu D.
    EMBO J. 18:4233-4240(1999) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-1226051.

    This publication is mapped to 2 other entries.

  10. 10
    "A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin."
    Thomas G.M., Frame S., Goedert M., Nathke I., Polakis P., Cohen P.
    FEBS Lett. 458:247-251(1999) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-1226051.

    This publication is mapped to 13 other entries.

  11. 11
    "Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification."
    Farr G.H., Ferkey D.M., Yost C., Pierce S.B., Weaver C., Kimelman D.
    J. Cell Biol. 148:691-702(2000) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-1226051.

    This publication is mapped to 2 other entries.

  12. 12
    "Identification of the Axin and Frat binding region of glycogen synthase kinase-3."
    Fraser E., Young N., Dajani R., Franca-Koh J., Ryves J., Williams R.S., Yeo M., Webster M.T., Richardson C., Smalley M.J., Pearl L.H., Harwood A., Dale T.C.
    J. Biol. Chem. 277:2176-2185(2002) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-1226051.

    This publication is mapped to 3 other entries.

  13. 13
    "Glycogen synthase kinase-3 beta mutagenesis identifies a common binding domain for GBP and Axin."
    Ferkey D.M., Kimelman D.
    J. Biol. Chem. 277:16147-16152(2002) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-1226051.

    This publication is mapped to 2 other entries.

  14. 14
    "Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism."
    Liu C., Li Y., Semenov M., Han C., Baeg G.-H., Tan Y., Zhang Z., Lin X., He X.
    Cell 108:837-847(2002) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-1226051.

    This publication is cited by 2 and mapped to 27 other entries.

  15. 15
    "Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex."
    Dajani R., Fraser E., Roe S.M., Yeo M., Good V.M., Thompson V., Dale T.C., Pearl L.H.
    EMBO J. 22:494-501(2003) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-1226051.

    This publication is cited by 1 and mapped to 21 other entries.

  16. 16
    "Characterization and functional analysis of the murine Frat2 gene."
    van Amerongen R., van der Gulden H., Bleeker F., Jonkers J., Berns A.
    J. Biol. Chem. 279:26967-26974(2004) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-1226051.

    This publication is cited by 1 and mapped to 8 other entries.

  17. 17
    "Frat is dispensable for canonical Wnt signaling in mammals."
    van Amerongen R., Nawijn M., Franca-Koh J., Zevenhoven J., van der Gulden H., Jonkers J., Berns A.
    Genes Dev. 19:425-430(2005) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-1226051.

    This publication is mapped to 23 other entries.

  18. 18
    "Re-evaluating the role of Frat in Wnt-signal transduction."
    van Amerongen R., Berns A.
    Cell Cycle 4:1065-1072(2005) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-1226051.

    This publication is mapped to 2 other entries.

  19. 19
    Category: Pathology & Biotech.
    Annotation: Not Associated with NEUROLOGICAL: Alzheimer's disease.Imported.
    Source: GAD:576502.

    This publication is mapped to 1674 other entries.

  20. 20
    "FRAT1, a substrate-specific regulator of glycogen synthase kinase-3 activity, is a cellular substrate of protein kinase A."
    Hagen T., Cross D.A., Culbert A.A., West A., Frame S., Morrice N., Reith A.D.
    J. Biol. Chem. 281:35021-35029(2006) [PubMed] [Europe PMC] [Abstract]
    Category: PTM / Processing.
    Source: PhosphoSitePlus:Q92837.
  21. 21
    "Frat oncoproteins act at the crossroad of canonical and noncanonical Wnt-signaling pathways."
    van Amerongen R., Nawijn M.C., Lambooij J.P., Proost N., Jonkers J., Berns A.
    Oncogene 29:93-104(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-1226051.

    This publication is mapped to 19 other entries.

  22. 22
    "Identification of 2-(4-pyridyl)thienopyridinones as GSK-3beta inhibitors."
    Gentile G., Bernasconi G., Pozzan A., Merlo G., Marzorati P., Bamborough P., Bax B., Bridges A., Brough C., Carter P., Cutler G., Neu M., Takada M.
    Bioorg. Med. Chem. Lett. 21:4823-4827(2011) [PubMed] [Europe PMC] [Abstract]
    Category: Structure.
    Source: PDB:3ZRK, PDB:3ZRL, PDB:3ZRM.

    This publication is mapped to 1 other entry.

  23. 23
    "Toward an understanding of the protein interaction network of the human liver."
    Wang J., Huo K., Ma L., Tang L., Li D., Huang X., Yuan Y., Li C., Wang W., Guan W., Chen H., Jin C., Wei J., Zhang W., Yang Y., Liu Q., Zhou Y., Zhang C.
    , Wu Z., Xu W., Zhang Y., Liu T., Yu D., Zhang Y., Chen L., Zhu D., Zhong X., Kang L., Gan X., Yu X., Ma Q., Yan J., Zhou L., Liu Z., Zhu Y., Zhou T., He F., Yang X.
    Mol. Syst. Biol. 7:536-536(2011) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Source: IntAct:Q92837.

    This publication is mapped to 2554 other entries.

  24. 24
    "5-Aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors."
    Gentile G., Merlo G., Pozzan A., Bernasconi G., Bax B., Bamborough P., Bridges A., Carter P., Neu M., Yao G., Brough C., Cutler G., Coffin A., Belyanskaya S.
    Bioorg. Med. Chem. Lett. 22:1989-1994(2012) [PubMed] [Europe PMC] [Abstract]
    Category: Structure.
    Source: PDB:4AFJ.

    This publication is mapped to 1 other entry.

  25. 25
    "Frat2 mediates the oncogenic activation of Rac by MLL fusions."
    Walf-Vorderwulbecke V., de Boer J., Horton S.J., van Amerongen R., Proost N., Berns A., Williams O.
    Blood 120:4819-4828(2012) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-1226051.

    This publication is mapped to 23 other entries.

1 to 25 of 30  Show

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health